Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

According to an article in Reader’s Digest, growing evidence shows that dancing can boost brain health and help manage ...

New diet drugs are making it easier to lose weight. So does that mean we can stop exercising? Health experts say no. There is ...

Harvard experts highlight the broad health benefits of exercise beyond weight loss, even with new diet drugs available.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

Pison Technology, led by veteran semiconductor executive John Croteau, is working with the watchmaker to integrate brain-sensing features into products.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...